Preventing Early Vascular Ageing (EVA) and its hemodynamic changes

Similar documents
Clinical application of Arterial stiffness. pulse wave analysis pulse wave velocity

Theoretical and practical questions in the evaluation of arterial function Miklós Illyés MD. Ph.D.

When should you treat blood pressure in the young?

Pulse wave velocity, augmentation index and arterial age in students

Estimated Pulse Wave Velocity Calculated from Age and Mean Arterial Blood Pressure

Causes of death in Diabetes

The Conduit Artery Functional Endpoint (CAFE) study in ASCOT

Blood Pressure Targets in Diabetes

Arterial function and longevity Focus on the aorta

The organs of the human body were created to perform ten functions among which is the function of the kidney to furnish the human being with thought.

Estrogens vs Testosterone for cardiovascular health and longevity

Arterial stiffness and central BP as goals for antihypertensive therapy in pre- and elderly. Piotr Jankowski

ASSOCIATION OF SYSTEMIC INFLAMMATION WITH ARTERIAL STIFFNESS IN HYPERTENSION

Diabetes Mellitus: A Cardiovascular Disease

The arterial system has a dual function:

Effects of Renin-Angiotensin System blockade on arterial stiffness and function. Gérard M. LONDON Manhès Hospital Paris, France

Central Pressures and Prehypertension

Background. Metabolic syndrome T2DM CARDIOVASCULAR DISEASE. Major Unmet Clinical Need. Novel Risk Factors. Classical Risk Factors LDL-C.

surtout qui n est PAS à risque?

Which method is better to measure arterial stiffness; augmentation index, pulse wave velocity, carotid distensibility? 전북의대내과 김원호

Rikshospitalet, University of Oslo

Association between arterial stiffness and cardiovascular risk factors in a pediatric population

Coronary artery disease (CAD) risk factors

HTA ET DIALYSE DR ALAIN GUERIN

Danno d organo bersaglio e rischio CV. Persiste un ruolo prognostico oltre la patologia d organo?

Endothelial function is impaired in women who had pre-eclampsia

Hypertension Management Controversies in the Elderly Patient

T. Suithichaiyakul Cardiomed Chula

Prevention of MACROvascular Complications of Diabetes

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital

Managing HTN in the Elderly: How Low to Go

Cardiovascular disease and diabetes Vascular harmony

D Terentes-Printzios, C Vlachopoulos, G Vyssoulis, N Ioakeimidis, P Xaplanteris, K Aznaouridis, E Christoforatou, A Samentzas, A Siama, C Stefanadis

Pharmacological modulation of vascular structure and function. L. Van Bortel. Heymans Institute of Pharmacology, Ghent University

Early Detection of Damaged Organ

Assessment of Arterials Functions: Is Pulse Wave Velocity ready forprime Time. Gérard M. LONDON INSERM U970 Hopital Georges Pompidou Paris, France

Dysglycaemia and Hypertension. Dr E M Manuthu Physician Kitale

How clinically important are the results of the large trials in hypertension?

INTERNATIONAL REGISTRY FOR AMBULATORY BLOOD PRESSURE AND ARTERIAL STIFFNESS TELEMONITORING

The Clinical Unmet need in the patient with Diabetes and ACS

Value of cardiac rehabilitation Prof. Dr. L Vanhees

APPLICATION OF PHYSICAL METHODS FOR DETERMINATION OF FUNCTIONAL PARAMETERS OF ARTERIES IN RHEUMATIC PATIENTS

Cholesteryl ester transfer protein inhibitors - what have we learnt? Philip Barter The Heart Research Institute Sydney, Australia

Antihypertensive Trial Design ALLHAT

The target blood pressure in patients with diabetes is <130 mm Hg

TODAY S TOPIC Blood Pressure & Pulse Wave Measurement Combined in One Procedure Re-classification of Risk Patients

Fasting or non fasting?

Central pressures and prediction of cardiovascular events in erectile dysfunction patients

PHENOTYPING FAMILIES OF A HYPERTENSIVE PATIENT

DISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE

Effects of Kidney Disease on Cardiovascular Morbidity and Mortality

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010

Changes in Blood Pressure and Vascular Physiology: Markers for Cardiovascular Disease

Case Presentation. Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer

Low grade inflammation and cardiovascular disease

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD

9/29/2015. Primary Prevention of Heart Disease: Objectives. Objectives. What works? What doesn t?

Isolated Systolic Hypertension in the elderly. Daniel Hayoz Clinique de Médecine Interne HFR-Hôpital Cantonal Fribourg

Η σημασία της αρτηριακής σκληρίας στην εκτίμηση της διαστολικής δυσλειτουργίας στην υπέρταση. Θεραπευτικές παρεμβάσεις

3 Aging, Arterial Stiffness,

1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria

Allopurinol reduces left ventricular hypertrophy and endothelial dysfunction in patients with chronic kidney disease

Cardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center

Inflammation as A Target for Therapy. Focus on Residual Inflammatory Risk

PULSE WAVE VELOCITY AS A NEW ASSESSMENT TOOL FOR ATHEROSCLEROSIS

INTRAUTERINE GROWTH RESTRICTION AND ITS IMPACT ON CARDIAC FUNCTION AND ARTERIAL COMPLIANCE IN THE YOUNG CHILD

Environmental. Vascular / Tissue. Metabolics

Arterial Age and Shift Work

Diversity and HTN: Approaches to optimal BP control in AfricanAmericans

An Epidemiological Overview

Departments of Cardiology and Vascular Surgery Michaelidion Cardiac Center University of Ioannina, Greece

Hypertension. Does it Matter What Medications We Use? Nishant K. Sekaran, M.D. M.Sc. Intermountain Heart Institute

Update in Hypertension

Preventive Cardiology Scientific evidence

Should we prescribe aspirin and statins to all subjects over 65? (Or even all over 55?) Terje R.Pedersen Oslo University Hospital Oslo, Norway

Impact of Aortic Stiffness on Further Cardiovascular Events in Patients with Chest Pain : A Invasive Study

Diabetes and the Heart

Management of Cardiovascular Disease in Diabetes

Antiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease. Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.

Traditional Asian Soyfoods. Proven and Proposed Cardiovascular Benefits of Soyfoods. Reduction (%) in CHD Mortality in Eastern Finland ( )

CONTRIBUTING FACTORS FOR STROKE:

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.

Hypertension: What s new since JNC 7. Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF

Arterial Stiffness: pathophysiology and clinical impact. Gérard M. LONDON Manhès Hospital Fleury-Mérogis/Paris, France

Μαρία Μαρκέτου Επιμ. Α Καρδιολογική Κλινική ΠαΓΝΗ

Cardiovascular Protection and the RAS

MANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION

Πρώιμη αγγειακή γήρανση στην υπέρταση: διάγνωση και αντιμετώπιση

ΛΟΙΜΩΞΗ HIV. Ιγνάτιος Οικονομίδης,MD,FESC Β Πανεπιστημιακή Καρδιολογική

The Diabetes Link to Heart Disease

Diabetes and Heart Failure

ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH

Arterial Pressure in CKD5 - ESRD Population Gérard M. London

Marginal donors: Young vs. Old

SUPPLEMENTAL MATERIAL

ARTERIAL STIFFNESS AND CORONARY ARTERY DISEASE

Relevance of sympathetic overactivity in hypertension and heart failure Therapeutic Implications

Cardiovascular Diseases in CKD

Transcription:

Translational Research 31 st October 2013, Moscow Preventing Early Vascular Ageing (EVA) and its hemodynamic changes Peter M Nilsson, MD, PhD Department of Clinical Sciences Lund University University Hospital, Malmö Sweden

Age and cardiovascular disease Age - a greater risk factor than traditional risk factors Age-related changes in vascular structure and function, in association with metabolic disturbances, are likely to be responsible for increased cardiovascular risk Increasing Age Increased exposure to risk factors Changes in the vessel wall Increase in CAD, Hypertension, CHF, stroke Najjar et al. Hypertension 2005; 46:454-462. O Rourke, Safar, Dzau. Vascular Med 2010

A man is as old as his arteries Thomas Sydenham 1624 1689 The English Hippocrates

Biological Age Chronological v Biological Ageing Age (years)

Danish Twin Register in Odense Left hand image represents twins who looked younger for their age (average perceived age 64, range 57-69) than those represented by right hand image (average perceived age 74, range 70-78 years). The older looking twin had more risk factors, shorter telomeres and a worse prognosis during follow-up. Christensen K, et al. BMJ 2009

The life course of human subjects

Life course across generations Vigeland Statue Park, Oslo, Norway

Birth weight and adult disease low birth weight (LBW) hypertension type 2 diabetes hyperlipidaemia insulin resistance metabolic syndrome vascular dysfunction coronary heart disease (CHD) osteoporosis 8.5 lbs 5.5 lbs depression and other psychopathologies LBW: caused by impaired fetal growth or preterm delivery

CVD risk in Russia Different levels of understanding Genetic factors Early life programming Influences in adolescence Adult lifestyle Working and living conditions Social stress Quality of health care Cultural factors

Growing up in the Soviet Union

Arterial ageing and stiffening Kotsis V, Stabouli S, Karafillis I, Nilsson P. Early vascular aging and the role of central blood pressure. J Hypertens. 2011 Oct;29(10):1847-53.

What is vascular ageing? Arterial stiffening (elastin, collagen ), increased pulse pressure (PP) and pulse wave velocity (PWV) when >12 m/s is risk Glycation of vessel wall proteins (AGE) Endothelial dysfunction Decreased NO production, oxidative stress Local and perivascular inflammation (CRP, IL) Capillary rarefaction and dysfunction Telomere shortening (attrition) Increased in hypertension in diabetes! London, October 2013

Sphyghmocor for PWV and Augmentation Index

Arteriograph for central pressure and arterial stiffness

Pulse Wave Velocity & Augmentation Index Uses Arterial tonometer (radial) Sphygmocor ongoing project at Clinical Research Department, University hospital, Malmo, Sweden

Carotid pressure waveform is recorded by applanation tonometry Copyright Laurent, restrictions S. et al. may Eur apply. Heart J 2006 27:2588-2605;

The Impact of the Early Wave Reflection D PP Increased Central Pulse Pressure Increased LV Load Decreased Coronary Artery Perfusion Pressure in Diastole This earlier return to the heart of the reflected pressure wave (due to stiffening of the arteries) changes the aortic root pressure waveform, with 3 key clinical implications Central pulse pressure increases... increasing risk of stroke and renal failure LV Load increases. increasing LV mass, and accelerating progress towards LV hypertrophy and heart failure Coronary artery perfusion pressure in diastole reduces. increasing risk of myocardial ischemia

Measurement of carotid-femoral PWV with the foot to foot method Copyright restrictions may Laurent, apply. S. et al. Eur Heart J 2006 27:2588-2605.

Eur Heart J 2010;eurheartj.ehq165 Laurent S, et al, for a Collaborative Group Normal values for pulse wave velocity average according to age (1455 healthy NT subjects) NT = normotensives (out of a total 16,867 subjects from 8 European countries)

Meta-analysis on individual data: independent predictive value of aortic stiffness for CV events (16,358 subjects) Y Ben Schlomo et al. ARTERY 11, Oct 2011 JACC 2013, accepted Age-specific HRs for CVD, per 1SD increase in log cf-pwv Category ES (95% CI) Age_Group <50 years 51-60 years 61-70 years >70 years 1.83 1.83 (1.33, 2.52) 1.67 1.67 (1.40, 1.99) 1.37 1.37 (1.17, 1.61) 1.25 1.25 (1.09, 1.43).8 1 1.4 1.8 2.2 2.6 Hazard Ratio (95% CI) 14 studies including 16,358 subjects with 1700 combined CVD events. z-scores of log transformed cf-pwv (pooled SD = 3.3m/s). Higher predictive value in younger subjects: (p-value for trend = 0.0095).

Vascular and brain ageing - cognitive decline normal atrophy microvascular lesion

J Hypertens 2005

Mitchell et al., Brain. 2011;134:3398-3407.

Mitchell et al., Brain. 2011;134:3398-3407.

Pathophysiology of EVA Large artery damage arterial stiffening Well identified CV risk factors (gender, BP, lipids, smoking, diabetes Poorly identified CV risk factors (infection-inflammation, oxidative stress, low birth weight, genetics, fetal programming, telomere length, increased sympathetic activity ) Mechanical and chemical stress Nilsson PM, et al J Hypertens 2013 Large/small artery cross-talk Small artery damage wall/lumen ratio and rarefaction EVA Inadequate repair mechanism Target organ damage - Myocardial ischemia - Reduction in GFR - Microalbuminuria - White matter lesions - Cognitive decline

Haemodynamic Ageing Syndrome (HAS) Age-related changes in brachial BP isolated systolic hypertension (ISH) elevated pulse pressure (PP) Age-related changes in central BP Increased central systolic BP and PP Increased BP variability Linked to arterial stiffness Decreased heart rate variability Linked to arterial stiffness Impaired endothelial function Less vasodilation Impaired baroreceptor function, orthostatic hypotension Linked to arterial stiffness PN 2013

EVA and HAS Age-related morphological changes in the arterial wall and its haemodynamic consequences

The Rotterdam Study N= 3362 Mattace-Raso F, et al. J Hypertens 2006; 24:339

Genetics

Genome-wide log 10 P-value plots and effects for significant loci related to BP SBP DBP Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011 Sep 11;478:103-9.

Summary of GWAS for PWV in the SardiNIA study cohort with controls from the Amish population (n= 1828) Conclusion: A genome-wide association study identified a SNP in the COL4A1 gene that was significantly associated with PWV in 2 populations. Collagen type 4 is the major structural component of basement membranes, suggesting that previously unrecognized cell-matrix interactions may exert an important role in regulating arterial stiffness. Tarasov K V et al. Circ Cardiovasc Genet 2009;2:151-158

Telomeres at the end of the DNA helix

Telomere structure: an overview Telomeres are the ends of chromosomes Human telomeres consist of TTAGGG repeats Function is to protect the ends of chromosomes from fusion or damage Nobel Prize in 2009

The Telomere Hypothesis of CAD Those individuals born with shorter telomeres may be at increased risk of CAD In addition to individual genes, a more global structural property of the genetic material may explain the familial basis of CAD Conventional risk factors for CAD may act partly via their effect on telomere biology Variation in telomere length may, at least in part, provide an explanation for the variability in both susceptibility to & age of onset of CAD Samani NJ & P van der Harst Heart 2009

Telomere length in healthy offspring of subjects with and without CAD S Brouilette et al. Heart 2008

Telomeres and Risk of Premature MI Study 203 patients with myocardial infarction before the age of 50 years 180 age-gender matched controls without history of CHD Measurement of leucocyte mean telomere length (LTL) Adjustment for age, gender, acquired and biochemical risk factors Brouilette et al ATVB 2003

Mean TRF (kb) Telomere shortening in premature MI 203 MI cases and 180 macthed controls 9.0 8.5 Cases Controls 8.0 7.5 7.0 6.5 6.0 5.5 5.0 11.3 years 35 40 45 50 55 60 Age (years) Brouilette et al. ATVB 2003

Risk of MI is progressively higher with shorter telomere length * * Brouilette et al, 2002. ATVB. Brouilette et al., ATVB, 2003.

Telomere length, CHD events and benefits from statin treatment in the WOSCOPS trial * * Tertile Placebo Statin 1 62 61 2 118 68 3 109 68 Brouilette et al. Lancet 2007

Telomere length in vascular cells in CAD Endothelial cells VSMCs Ogami et al. ATVB 2004 Matthews et al. Circ Res 2006

Genetic markers for the biology of telomeres and CAD risk Data are displayed as log10(p values) against chromosomal location for the 2,362,330 SNPs that were tested. The dotted line represents a genome-wide level of significance at P = 5 10 8. Loci that showed an association at this level are plotted in red. Codd V, et al. Nat Genet.2013 Apr;45:422-7

CAD risk Forest plot showing the effect of telomere length on CAD risk obtained for each SNP using a risk score analysis for each SNP. Effect sizes are plotted with 95% confidence intervals. The overall estimate is from a fixed-effects meta-analysis over all SNPs, where the odds ratio (OR) relates to the change in CAD risk for a S.D. change in telomere length. Codd V, et al. Nat Genet.2013;45:422-7,

Arterial wall Time course of Early Vascular Ageing (EVA) and possible intervention by Aggressive Decrease of Atherosclerosis Modifiers (ADAM) in CVD risk patients 100% damaged Period of early detection and successful regression ADAM (late stage) ADAM (earlier stage) EVA 100% normal normal vascular aging Time Nilsson PM, Laurent S. et al. Hypertension 2009

Inverse correlation between omega-3 fatty acid intake and telomere attrition rate Farzaneh-Far R et al. JAMA 2010

Proposed scheme for the mechanisms by which caloric restriction and the caloric restriction mimetic resveratrol confers vasoprotection Ungvari Z et al. J Gerontol A Biol Sci Med Sci 2010;65A:1028-1041

The Look AHEAD Research Group. NEJM June 24, 2013 Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes Look AHEAD

Summary Early life programming is of importance for shaping susceptibility to some chronic diseases in adult life Environmental (nutrition, smoking, stress), obstetric (placenta), genetic (maternal) and epigenetic factors are of importance for fetal growth and organ development Arterial stiffness (arteriosclerosis) precedes atherosclerosis, plaque formation and clinical events Early vascular ageing (EVA) could be influenced by less elastin content in the arterial wall in former IUGR babies PN 2013